Tag Archives: dispensary

What Your Dispensary’s POS Data Doesn’t Tell You About Your Customers

By Tony Ciovacco
No Comments

A dispensary’s point-of-sale system keeps the most complete record in the building. It knows the SKU, price, discount, time of day, the budtender who rang it up, and, if the customer is enrolled in loyalty, who they are and how often they return. For inventory, reorders, promotions, and compliance reporting, that record is exactly what an operator needs.

It also ends when the repeat-purchase decision begins.

Whether a customer comes back is not settled at the counter. It is settled hours later, at home, when the product either does what the customer bought it for or does not. The receipt captures the transaction in detail but nothing about the outcome. Most customer retention strategies rely on the first record and guess at the second.

 

What the POS Actually Knows

Cannabis POS and loyalty platforms are good at recency, frequency, and spend. They can tell you who has not been in for 30 days, which categories a customer buys, and what basket size looks like by daypart. Layer in a loyalty program and you can attach points, tiers, and targeted offers to all of it.

Every one of those signals describes behavior. None of them describes experience. A repeat purchase is an outcome, and the POS records the outcome without its cause. That distinction sounds academic until you look at two customers with identical receipts.

 

Two Identical Receipts

Consider two customers who buy the same product on the same Friday afternoon, at the same price, with the same loyalty discount. In the POS, they are the same row.

The first bought it to unwind after work, and it did exactly that. She will be back next week and will probably ask for it by name. The second bought it for the same reason and spent the evening restless and unsettled. He will not complain, ask for a refund, or leave a review. He will quietly try another store next time, or come back to yours and pick something different with no record of what went wrong.

Nothing in the transaction data distinguishes them. A recency report will flag the second customer only after he has already gone, and by then the reason is unrecoverable.

 

Why the Label Does Not Close the Gap

The obvious objection is that product attributes should predict experience. If a store knows what it sold, it knows roughly what the customer felt.

The research suggests otherwise. A 2022 analysis of commercial cannabis across six U.S. states found that the common labels attached to products, including indica, sativa, and hybrid, do not consistently align with the products’ measured chemical profiles. Potency is not a reliable proxy either. In a University of Colorado study, participants assigned to higher- or lower-THC flower and concentrates showed very different levels of THC in their blood, yet the researchers concluded that differences in short-term subjective effects “did not track specifically with strength of the cannabis consumed.”

Add format and the variability widens. An edible, a vape cartridge, a tincture, and a pre-roll can produce different onsets, durations, and experiences for the same person. The label describes the product. It does not describe what happened to the customer, and it was never designed to.

 

A Structural Gap, Not a Missing Feature

The temptation is to treat this as a software problem: add a survey, add a rating field, buy another dashboard. But the gap is structural. The experience happens off premises, and after the sale, in a window no retail system observes. It varies by person, product, and format, so you can’t infer it from the SKU. And the only bridge most stores have, the budtender who remembers what a regular said last time, is the least durable asset in the business. When that employee leaves, the store loses the knowledge of why its best customers come back.

That is the real cost. Operators do not lack data. Their data answers questions they don’t need answered and says nothing about the one that drives retention.

 

What Operators Can Do Now

None of the following requires new software, and most of it can start this week.

Ask the after-sale question on purpose. When a known customer returns, the most valuable thing a budtender can ask is how the last purchase worked for them. Make it a standard part of the second visit, not an improvisation.

Record the answer in a structured way. A free-text note that says “liked it” is nearly useless at scale. Three fields are enough: what the customer wanted from the product (sleep, relief, focus, socializing, unwinding), whether it delivered (yes, partly, no), and the format they used. Most POS and CRM systems already have a profile notes field for this.

Recommend in outcome language. If the counter conversation starts with how the customer wants to feel rather than with THC percentage or strain type, the follow-up question has something to measure against. “Did it help you unwind?” is answerable. “Did you like the 28 percent?” is not.

Read basket changes as a signal. A customer who switches categories or brands every visit may be exploring. They may also be searching for something that works but can’t find it. Without the experience data those two customers look the same, and only one of them is at risk.

Make the knowledge outlive the employee. Whatever staff learn about why a customer returns belongs in the system, not in one person’s memory. Turnover is a fact of cannabis retail. Losing your retention intelligence every time someone quits does not have to be.

Where state rules permit follow-up outreach, build it around the experience, not the discount. A message that asks how a product worked earns information. A coupon earns a transaction and teaches you nothing.

 

The Second Question

The receipt will always be the best record of what sold. It will never tell you why someone came back. Operators who build that second record, one structured conversation at a time, will understand their customers in ways transaction data alone cannot, and they will see churn coming while there is still time to act.

 

How a Simple 3-Email Sequence Drove ROI for This Dispensary

By Stephen Gold
No Comments

How do you win back customers who drifted away? You know the type: they used to come into your dispensary regularly, then just stopped. No complaint, no goodbye. They found a shorter line, a better deal, or a store closer to home. Competition is fierce, but you don’t need a massive ad budget to get them back through your door. In a market with a dispensary on every corner, that quiet drift is where most of your revenue is leaking out, and it’s the easiest leak to plug.

Think about what it cost you to acquire that customer in the first place: the ad spend, the first-visit discount, the labor of capturing their email and phone number. You did all the hard work already. Then you let them lapse and spend their money three blocks away. That isn’t a lost customer; it’s a paid-for customer you are choosing to ignore.

A lot of these lapsed customers are technically still on your list, sitting in your weekly blast emails and texts. But being in the send queue is not the same as being reached. When someone receives a generic promo from three different dispensaries every single day, one more batch message is just background noise. If you’re advertising 25% off a product they can get down the street for the exact same price, you aren’t advertising a deal—you are advertising standard retail. To a drifting customer, that gives them a reason to stay away, not a reason to return.

We tested exactly how much revenue is sitting inside that segment. For one dispensary client, we built a targeted winback sequence aimed strictly at customers who hadn’t purchased in 60 or more days—the group most platforms write off as unreachable.

The Case Study: Gold Standard Dispensary Winback

  • The Strategy: A three-touch email sequence sent to customers inactive for 60+ days, offering a simple 20% discount.

  • The Execution: Sent manually with zero expensive automation software.

  • The Results:

    • 49 attributed conversions from the first send alone.

    • 3,240% ROI on the lead send, ranking as a top-10 ROI campaign across the entire account.

    • Long-term impact: A significant percentage of reactivated buyers resumed regular purchase habits at full margin over the following 90 days.

 

The Winback Playbook & Execution Blueprint

To replicate these results, you need more than a single discount email. You need a structured cadence, the right timing, and actionable copy.

1. Catch Them in the 60-Day “Money Window”

Think in 30-, 60-, and 90-day tiers:

  • 30 Days: A light “we miss you” nudge is plenty.

  • 60 Days: This is the sweet spot. Long enough to confirm they have genuinely drifted, but short enough that your brand is still fresh in their mind.

  • 90+ Days: You are entering cold reactivation territory, which requires steeper discounts and aggressive messaging.

2. Ready-to-Use Email Swipe Copy & Cadence

Do not rely on a single email. The lift comes from a three-touch sequence where each message serves a specific purpose:

Email 1 (Day 60) — The Conversational Hook

  • Subject Line: We miss you, [First Name] (Here’s 20% off your next visit)

  • Body Copy:

    Hi [First Name],

    It’s been a minute since we’ve seen you at [Dispensary Name]. We know you have plenty of choices when it comes to stocking up, but we’d love to welcome you back.

    Here is 20% off your next order on us. Just show this email to your budtender or use code WELCOMEBACK20 online.

    [Claim Your 20% Off Button]

Email 2 (Day 63) — The Value Nudge

  • Subject Line: Still got that 20% off pass, [First Name]?

  • Body Copy:

    Hi [First Name],

    Quick reminder: Your 20% off pass is still active. Whether you need to restock your go-to flower or want to try something fresh on our menu, we’ve got you covered.

    Your code WELCOMEBACK20 is valid through [Day of Week].

    [View the Menu & Save]

Email 3 (Day 65) — The Last Call Urgency Pass

  • Subject Line: [LAST CALL] Your 20% discount expires tonight

  • Body Copy:

    Hi [First Name],

    Last call! Your 20% savings pass expires at close of business today.

    Stop by [Dispensary Name] before [Closing Time] or place your online order before midnight to lock in your savings.

    [Use Code WELCOMEBACK20 Now]

3. How to Query Your POS / CRM (Technical Setup)

You don’t need complex software to pull this list. Whether you run Dutchie, Treez, Jane, Alpine IQ, or Springbig, use these exact filtering parameters:

  1. Date Range Filter: Set Last Purchase Date to > 60 Days Ago AND < 90 Days Ago.

  2. Exclusion Rules: Exclude any contact tagged as Opted Out, Employee, or with an Active Pending Order.

  3. Segmentation Tag: Tag this group as Winback_60D_Batch1 so you can measure lifetime value (LTV) recovery over 30, 60, and 90 days following the campaign.

 

4. SMS vs. Email: Channel Strategy & Compliance

While email allows for visual menus and storytelling without risk of carrier restrictions, SMS offers ~98% open rates. If you utilize SMS alongside email, keep these delivery rules in mind:

  • Email: Best for Message 1 and Message 2. Zero risk of carrier fines and plenty of room to highlight new inventory.

  • SMS: Highly effective for Message 3 (The “LAST CALL” push).

  • Compliance Note: Ensure your SMS copy strictly avoids prohibited keywords (e.g., explicit federal drug references or aggressive promotional terms depending on state regulations and carrier filters). Always include standard STOP to opt out language to protect your sender reputation under TCPA rules.

5. The LTV Math: Why 20% Off Retains Profit Margins

A common objection from dispensary owners is: “I don’t want to give up margin on customers who might have come back anyway.”

The math disproves this fear:

  • Cost of Acquisition (CAC) for New Buyers: $25–$40+ in local ads, sponsorships, and initial sign-up discounts.

  • Cost of Winback: $0 in ad spend + a $10 margin concession on a $50 basket.

  • Net Revenue: A customer who was generating $0 for two months generates $40 today and will average $300–$500 in full-margin revenue over the next six months once restored to regular purchasing habits. You aren’t discounting a loyal buyer; you are buying back an asset you already paid for.

 

Stop Chasing Strangers

The most expensive customer you will ever acquire is a brand-new one. The cheapest customer is the one who already knows your store, has handed over their contact information, and simply needs a clear reason to walk back through your door.

Stop pouring budget into cold audiences. Filter your list, run the cadence, and go claim the revenue sitting in your database.

How Cannabis Brands Plan To Drive Retail Sales in 2026

By Cannabis Industry Journal Staff
1 Comment

 

Retailers are not in the business of building brands. They are in the business of selling products. The most effective way to earn buyer attention is still the same: proven sales velocity paired with brand awareness that brings customers through the door.

Retail Is the Battleground

Brendan McKee, co-founder of Massachusetts dispensary Silver Therapeutics, wants brands to fully commit to retail partnerships. “Brands that we have in store and collaborate with in more meaningful ways share dedicated emails and social posts with their customers,” he said. “For new store openings and operating locations, brands bring in food trucks, pop-up materials, merch giveaways, and product discounts.” The store also offers co-branded print and digital ads from brands to amplify collective reach. “It is a beautiful thing when brands show up for our teams and retail locations. We are always better together,” added McKee.

Jesse Tolz, VP of Marketing at Gotham dispensaries in New York, agrees that experiences leave a deeper impression than discounts. “The most effective strategic partners invest in experiences that build brand awareness,” he said. “Product collaborations and experiential activations consistently outperform traditional promotions because they create emotional attachment rather than relying solely on transactional incentives.”

Tolz pointed to an upcoming event built around Gotham Goods’ line of body and home essentials, anchored in the idea that ritual is a catalyst for connection. The Feb. 10 launch will introduce the collection through an immersive evening of scent discovery and product sampling at Gotham Gallery in Chelsea, Manhattan.

For Monica Olano, founder of Cali Sober Market in Louisiana, the most powerful in-store marketing tactic is still human-to-human connection at the point of sale. “On any given day, I can predict which SKUs will move best based on who’s working, because they believe in those brands and understand the ingredients and effects,” she said. “Brands that treat getting on the shelf as the finish line will stall. The ones that win treat it as the starting point by investing in staff education, relationships, and ongoing presence.” When employees become believers, they don’t just drive sales; they become advocates.

 

How Brands Are Showing Up at Retail

As the industry matures, consumers are increasingly walking into dispensaries with specific brands in mind. Still, standing out remains difficult in a crowded market when everyone basically sells the same thing and competes on the same promotions. In categories where vapes and gummies are largely built on distillate and flavor innovation, brands cannot afford to let their marketing guard down. Should brands focus on multiple marketing levers or execute a few tactics really well? What’s the best way to impact the customer’s experience?

For Olio, a Colorado-based craft brand focused on live resin and rosin, driving retail sales starts outside the dispensary. Chief Marketing Officer James C. says his team prioritizes education-forward social settings, such as crafting sessions, recurring community events, and terpene pairings, that allow consumers to engage with the brand in a relaxed, hands-on environment. According to James, these experiential activations consistently outperform in-store pop-ups when it comes to creating first-time buyers.

At Alibi, budtenders are the focal point. “They are the ones guiding the purchase, so when they truly understand the product and the story behind it, sales follow naturally,” said Marianne Cursetjee. The brand invests heavily in budtender education, both in person and online, ensuring staff are eager to recommend Alibi on the floor.

Ryan Hunter, Chief Revenue Officer at Colorado-based Spherex, agrees that budtenders are the true gatekeepers. He warns that a single recommendation at the counter can change a shopper’s decision instantly. A budtender who recommends your product or wears your logo, he said, is worth more than any billboard.

Hunter added that the smartest teams show up consistently in dispensaries, but not through flashy pop-ups that reach only a handful of shoppers. Instead, they invest in long-term retail partnerships, supporting staff with simple gestures like lunch, swag, or operational support. “An effective cannabis marketing program supports the entire funnel,” he said, “from first awareness through repeat purchase.”

Carol Tyson, the Director of Marketing for Jaunty, a leading New York producer, emphasized their efforts to increase basket size in stores.

She said, in 2026, brands need to think less about one-off moments and more about creating repeatable levers that actually help retailers sell more product per visit. “For us, education and visual merchandising still matter—but only if they’re directly tied to increasing basket size and brand recall,” she said.

“Budtenders are our first customers. When they understand how a product fits into a consumer’s routine—whether that’s daytime focus, social use, or winding down—they’re better equipped to recommend complementary products and build a multi-item basket. That’s where in-person education still wins,” adds Tyson. “It’s not just about sampling; it’s about giving budtenders the language and confidence to upsell thoughtfully.

On the merchandising side, shelf space is incredibly competitive, especially in New York. So they invest in displays and menu placements that work harder—clear visual cues, simple product architecture, and messaging that helps consumers quickly understand the brand and what to add next. “When a display helps a consumer self-navigate or sparks a conversation that leads to a second or third item in the basket, that’s when marketing dollars are actually doing their job,” she explains.

Tyson believes the brands that will win in 2026 are those that align their marketing with retail outcomes—sell-through, basket size, and repeat purchase.

David Paleschuck of the Branding Bud Consulting Group agrees that retail success comes from orchestration, not isolated tactics. “There is no single tool, tactic, or growth hack that drives retail success on its own,” he said. “The real power comes from linking systems together to create relevance.”

By aggregating location data, weather patterns, local events, holidays, calendar timing, and past purchase behavior, brands can trigger messaging that feels timely rather than promotional. A rainy weekend, a local concert, or a replenishment window can all inform what gets promoted and when. “In 2026,” Paleschuck said, “the brands that win at retail will not be the ones with the cleverest campaign. They will be the ones that turn multiple data points into offers that feel personal, contextual, and genuinely useful.”

 

Consumer Insights: Where Brands Are Winning and Falling Short

No amount of marketing will generate repeat purchases if the product fails to meet consumer expectations. But across markets, consumer feedback also shows that winning brands are delivering on quality and consistency.

To understand how legal cannabis is landing with consumers, we reviewed discussions and reviews across Reddit and Yelp in California, Colorado, and New York. While criticism is common, particularly around flower quality and potency accuracy, positive feedback reveals clear opportunities for brands that get the fundamentals right.

In California, where consumers are arguably the most discerning, experienced shoppers consistently reward brands that prioritize flavor, smoothness, and strain integrity. Craft flower brands known for terpene-forward profiles and clean smoke are frequently praised, especially by consumers who say they are willing to pay more for products that taste good and deliver quality. Edibles also perform well in the state, with gummy brands earning praise for reliable dosing, consistent onset, and pleasing flavor profiles.

Colorado consumers are more divided, particularly around flower freshness and potency labeling, but positive feedback emerges when quality expectations are met. Consumers routinely praise dispensaries and brands that offer fresh product, clear lab results, and honest potency claims. When products deliver as advertised, shoppers are quick to leave high ratings and recommend them to others.

In New York, where the legal market is still maturing, consumers are vocal about shortcomings but equally clear about what works. Edibles receive some of the strongest praise, especially when effects are consistent, and labeling feels accurate. Shoppers also respond positively to well-curated retail experiences, knowledgeable staff, and brands that feel intentional rather than rushed to market. Even as flower quality remains a common complaint, consumers note that when they find a product that hits properly, they remember the brand and actively seek it out again.

Across all three states, consumers showed they will make repeat purchases when brands deliver a fresh, crafted, quality product. While marketing, activations, and retail partnerships are essential, they only work when the product experience hits home.

 

The State Of New York’s Cannabis Industry 2025

By Pam Chmiel
No Comments

Jason Ambrosino, a disabled Army veteran and founder of Veterans Holdings, entered the New York market in 2019 under the state’s hemp program with the goal of cultivating and manufacturing cannabis. But despite holding a 5,000-square-foot indoor cultivation license, he decided not to build out his facility. The reason, he says, is simple: “The registered organizations (ROs) in New York State own the flower industry. They own it. You’re not going to break in.”

Ambrosino explained that the state’s vertically integrated ROs, many of which started as medical operators, dominate the adult-use flower market with massive 100,000-square-foot indoor canopies and the ability to negotiate favorable energy rates. “The number one driver of indoor flower price anywhere is electricity cost,” he said. “Where I am in New York State, it’s 23 cents a kilowatt hour. The ROs can negotiate directly for 7, 8, or 9 cents per kilowatt-hour because of their size. There will never be a day when I can operate in the market alongside them, because it costs me twice as much to grow as it does them.” He said that disparity makes small-scale cultivation unviable for most new entrants.

Ambrosino estimates that it could cost him roughly $600 per pound to grow cannabis, while the ROs can do it for about half that. “You don’t really think about it until you end up paying for a license, only to find out the utility prices are so high that you can’t make it work,” he said.

He believes the state’s adult-use rollout created an illusion of opportunity for small hemp farmers and microbusinesses. “They used the illusion of inclusion to gain public support,” he said. “They built protections that were meant to keep ROs out for three years to create a level playing field, but these protections were stripped away after enough lobbying dollars were spent.”

According to Ambrosino, large operators pressured lawmakers by withholding financial commitments to social equity programs until they received favorable terms. “They held them hostage,” he said. “They told lawmakers, ‘We’re not going to pay you any of that money until you give us a more favorable law.’ So, they changed it.”

The result, he says, is a market where ROs hold most of the canopy, while smaller cultivators face high costs, limited access, and few realistic paths to profitability. “Right now, microbusinesses are structured for failure,” Ambrosino said. “They’re trying to sell flower at $60 when dispensaries can get indoor-grown product from ROs for $30 or $35. You can’t compete with that.”

Mismatched Policy, Manipulated Data, and a Market Set to Run Dry

Ambrosino says the Office of Cannabis Management (OCM) has failed to recognize the growing imbalance between large registered organizations and small cultivators. “The data OCM puts out is very manipulated and questionable,” he said. “They conflict with what they report from one day to the next. One day, there’s not enough canopy, the next day, there’s too much. It’s all over the place. They’ll show you all the potential canopy of adult-use license holders, but the reality is 80% of them aren’t growing, or they’re only using part of their allotted space. Meanwhile, the ROs are operating at a massive scale.”

He believes this disconnect has led policymakers to think there’s an oversupply problem when in reality there’s a shortage of affordable biomass. “OCM looks at flower canopy, not biomass canopy,” Ambrosino said. “We don’t have enough biomass to produce distillate, and distillate is what sets the price for everything.”

Ambrosino, who sits on the board of the Association of New York Cannabis Processors, says the solution starts with expanding outdoor cultivation. “We’ve been lobbying the state to raise the outdoor cap from one acre to five,” he explained. “They keep saying there’s enough canopy, but that’s not true if you want a functioning processing and manufacturing sector.”

He also believes OCM steered small farmers in the wrong direction. “They convinced these guys to grow indoors when they had no capital to begin with,” he said. “Outdoor grows are cheaper, more sustainable, and can produce terpene-rich material that’s perfect for extraction. Giving up those outdoor licenses was the worst thing they could have done.”

Ambrosino sees the industry’s structural problems fueling a deeper issue: product inversion. “Inversion is like a cancer tumor,” he said. “Everyone — dispensaries, processors, cultivators — is supporting it. If OCM just cuts it out overnight, the market will bleed to death. We have to shrink the tumor first. The only way to do that is to expand cultivation enough that it doesn’t make sense to invert.”

Licensing Gridlock and Market Whiplash

Dispensary operators say New York’s market isn’t just constrained by bureaucracy, it’s tangled in its own rules. Jon Paul Pezzo, owner of NYC Bud dispensary, believes the state’s proximity restrictions have unintentionally frozen the licensing process. “You have a lot of people that are holding proximities because they’re in the December queue or they just have a proximity,” he explained. “Some may have abandoned their license or run out of money, but those spots are still locked up. That means someone with an actual license can’t move forward.” Pezzo said that while rolling out the market slowly may have helped at first, the process has caused problems on all sides.

Now that the agency is considering waiving its 1,000-foot proximity rule to allow more dispensaries to open, Pezzo worries it’s too soon for such sweeping changes. “The industry isn’t even five years old,” he said. “Let it play out before you start rewriting the rules. If we had known these laws would change this quickly, maybe we would have invested differently.”

He added that while OCM claims to solicit feedback from operators, the process feels one-sided. “I’ve been to many OCM meetings where everyone’s frustrated, and the regulators just sit there getting yelled at,” he said. “At some point, they just shut down. I don’t think they’re really listening to logic.”

The Data Gap: METRC, Testing, and a Lack of Standards

Ambrosino believes New York’s lack of standardized testing and tracking has left the industry vulnerable to chaos. “If you want a juicy nugget, I’ll tell you where to look,” he said. “It’s in the testing, and it’s in the labs. If you dig deep enough, you’ll find that all of our labs are invalid because they were supposed to be updated by Wadsworth Labs, the state police lab that never got the equipment. Because of that, every lab is operating under its own standard. There’s no standardization between labs, and nobody knows.”

That lack of consistency, he warns, could have far-reaching financial consequences. When potency-based taxes were imposed, each lab’s different results meant the state effectively collected taxes on unverified data. “Don’t be surprised if people start demanding money back for what they overpaid in potency taxes,” Ambrosino said.

A long-promised track-and-trace system could have helped prevent some of this disarray, but the rollout has been repeatedly delayed. After three years, the agency now says METRC will finally be implemented in January.

Jon Paul Pezzo says the delay has left retailers struggling with manual systems that are prone to human error. “In a perfect world, this should work like a supermarket—product comes in, product goes out, and it’s all scanned into one universal system,” he explained. “Instead, we’re manually entering everything, and that leads to mislabeled products and bad data. For something that’s a controlled substance, that’s unacceptable.”

He believes a fully integrated METRC system could finally bring order to the process. “You’d have cultivators logging shipments, dispensaries scanning them in, and all the details automatically syncing,” Pezzo said. “It would make everyone’s life easier and protect the business as a whole. I just don’t understand why it’s taken this long.”

The Hemp Loophole is Undermining New York’s Legal Market

“The entire industry is using the hemp loophole,” Ambrosino said, describing a troubling double standard: OCM forced him to remove hemp-derived products from his website even though the regulations permitted out-of-state sales for products under the .3% threshold, while companies like Sluggers continue to sell high-potency “THCA hemp” products directly to New Yorkers online.

“This stuff they’re calling hemp, it’s not hemp, it’s marijuana,” he said. “We have to be smarter. It’s deceptive, and it’s hurting the legal operators who are trying to play by the rules.”

Ambrosino says that without proper lab oversight and product tracking, hemp-derived cannabinoids like THCA are slipping through regulatory cracks, further undermining the licensed market.

Cannabusiness Sustainability

Why Franchises Could Be the Golden Ticket for Social Equity Entrepreneurs

The cannabis industry is a fertile ground for aspiring entrepreneurs, holding the promise of a modern-day gold rush. Yet beneath the surface of opportunity lies a minefield of obstacles. Success requires navigating a steep learning curve, managing high operational costs, and mastering a complex supply chain that spans cultivation, manufacturing, consumer packaged goods (CPG), retail, finance, and strict regulatory compliance.

As of today, 40 states have legalized medical marijuana, and 24 states have legalized adult-use. Many of these states have prioritized giving Black and Brown communities, disproportionately harmed by the war on drugs, the chance to participate as dispensary owners. They’ve introduced social equity licensing programs, grants, and funding opportunities designed to level the playing field. Unfortunately, despite the good intentions, no state has yet launched a truly successful social equity program. New York’s rollout, in particular, has been marred by delays, lawsuits, and a lack of adequate support for license holders.

Despite the focus on prioritizing social equity entrepreneurs, the issues of inexperience, undercapitalization, and limited access to resources still need to be solved. These weaknesses create a high risk of business failure, making venture capital firms hesitant to invest in such ventures. A potential solution lies in franchising—a model that can provide a blueprint for success and the operational support to reduce failure rates, while also making cannabis investments more attractive to institutional and private investors.

 

The Benefits of a Retail Operational Blueprint

A cannabis franchise offers entrepreneurs an accelerated path to market by providing turnkey support. A franchisor supplies comprehensive resources, including:

  • Retail site selection and lease negotiations
  • Store design and build-out assistance
  • Initial and ongoing training programs for staff and management
  • Standardized operating procedures (SOPs) and compliance frameworks
  • Technology stacks (POS, e-commerce integration, track-and-trace systems)
  • Marketing and branding support rooted in consumer research
  • Vendor and supply chain relationships to ensure consistent, quality product flow

For new operators, this guidance eliminates many common pitfalls and shortens the learning curve. Franchisees step into a proven system, benefiting from brand recognition, operational discipline, and shared best practices.

 

Why Cannabis Franchises Make Sense

Cannabis retail faces unique challenges compared to traditional industries. Franchising can help overcome them:

1. The Unique Shopping Experience                              For first-time consumers, visiting a dispensary can feel intimidating. From security check-ins to navigating hundreds of unfamiliar products with the guidance of budtenders, the process can be overwhelming for new customers. A franchise ensures a consistent retail experience by training staff to educate and guide consumers, fostering customer loyalty, and building trust in the brand.

2. Adapting to Rapid Product Evolution                                                                          The cannabis product landscape changes faster than most consumer categories. Cultivators constantly rotate new strains into the market, novel cannabinoids (like THCV and CBG) are gaining traction, and new delivery systems, from solventless concentrates to nanoemulsion THC beverages, continue to emerge. A single dispensary may struggle to keep up with these trends, but a franchise leverages data from multiple locations to predict consumer demand and optimize inventory.

3. Navigating the Dispensary Technology Stack                                                  Dispensaries operate within a specialized tech ecosystem, featuring seed-to-sale tracking, compliance reporting, CRM systems, digital menus, and marketing platforms that must comply with advertising restrictions. Choosing the wrong software can be costly and disruptive. Franchises streamline this by standardizing their tech stack across locations, saving franchisees the trial-and-error process.

4. Meeting High-Security Requirements                                                                  Cannabis retailers must operate like high-security facilities. State-mandated vaults for product storage, video surveillance systems, onsite security guards, and cash-only operations (due to limited access to banking) make security both costly and complicated. Franchises reduce risk by providing tried-and-true protocols for safeguarding cash and inventory.

5. Ensuring Compliance in a Highly Regulated Industry                                  Compliance violations are among the fastest ways to lose a license. Cannabis retailers must adhere to strict regulations regarding packaging, labeling, advertising, delivery, consumption lounges, and track-and-trace systems. Non-compliance can result in severe fines or a permanent shutdown. By joining a franchise, operators gain access to dedicated legal and compliance teams who track evolving laws across multiple jurisdictions. This lowers the cost of legal services and dramatically reduces regulatory risk.

 

Easing the Path to Capital

Access to capital remains one of the biggest hurdles in cannabis. Traditional bank loans are rare, and investors are cautious due to the sector’s volatility. A franchise model eases this barrier by offering:

  • Proven systems and financial performance data that reduce investor risk.
  • Scalable retail expansion opportunities that appeal to venture firms and private equity.
  • Institutional credibility through established brands makes lenders more comfortable underwriting loans.

 

Challenges for Cannabis Franchisors

While franchising offers clear advantages for operators, it’s not without challenges. Only a handful of cannabis franchisors exist today, and some early attempts have failed due to the complexities of operating across multiple states, each with its own licensing rules, ownership caps, and compliance hurdles.

Two companies leading the charge are Sweet Spot Farms and Curio Wellness’ Far & Dotter, each approaching the franchise model in distinct ways.

  • Sweet Spot Farms has taken a cannabis-first approach, focusing exclusively on dispensary retail. With franchisees already operating in four states and more expansion underway, the company emphasizes a consistent retail experience, standardized operating procedures, and brand trust built directly around cannabis. Their success demonstrates that a disciplined, tightly controlled model can scale even in fragmented markets.
  • Far & Dotter, developed by Maryland-based MSO Curio Wellness, takes a broader health-and-wellness approach. In addition to cannabis retail, the franchise concept incorporates holistic services such as massage therapy, acupuncture, and natural health products. This wellness-forward positioning aims to destigmatize cannabis, attract new customer demographics, and differentiate Far & Dotter from dispensaries that focus strictly on THC sales.
  • Buds Place has yet to open its consumption lounge model, but is eyeing Michigan as its first state because of its more favorable cannabis laws compared to other states. Ron Silberstein, CFO, has been in the franchise industry since 1999 and believes the cannabis industry is the next great frontier for franchising opportunities.

The existence of these two models highlights both the opportunities and the complexities of franchising in the cannabis industry. Sweet Spot Farms shows how a cannabis-focused franchise can scale through disciplined operations, while Far & Dotter demonstrates how expanding the consumer experience beyond cannabis can open doors to new markets and investors. Both face the challenge of adapting their systems to varied state regulations while keeping brand consistency across locations.

Unlocking Potential Through Franchising

The cannabis industry is brimming with opportunity, but breaking in and building a sustainable business remains a daunting task. Franchising provides a proven roadmap that mitigates risk, accelerates growth, and increases access to capital. By offering operational blueprints, established brand trust, compliance expertise, and consumer insights, cannabis franchises create a supportive ecosystem for entrepreneurs.

Just as importantly, franchising can help advance social equity goals. By providing new entrepreneurs, especially those disproportionately affected by prohibition, a structured, proven path to success, franchising can democratize opportunities while attracting the investor capital the industry desperately needs.

If cannabis is the modern-day gold rush, franchising may well be the map that ensures more entrepreneurs strike success.

From The Lab

MJBowl Comes For New York Brands

By Pam Chmiel
No Comments

MJBizCon, the largest and one of the most influential gatherings in the cannabis industry, is adding a new element to its lineup: a cannabis competition.

This year marks the debut of the MJBowl awards on December 4th in Las Vegas, produced in partnership with Budist, the first-ever review platform to combine consumer feedback with expert ratings from seasoned professionals.

Elevating Cannabis Standards

Often compared to Wine Spectator, the influential magazine known for expert ratings, detailed tasting notes, and industry news, Budist applies a similar model to cannabis.

“Cannabis needed a professional ratings and review platform that elevates a brand’s standards,” said Claudio Miranda, co-founder and COO of Budist. “Just like wine, coffee, or craft beer, cannabis deserves a transparent, unbiased system for measuring quality.”

The inaugural event will feature separate competitions in California and New York, with winners crowned in each state. While future editions may pit markets against one another, for now, the MJBowl is designed as a celebration of excellence rather than a direct state-to-state showdown, since cannabis remains federally illegal and cannot be shipped across state lines.

Driving Premiumization in Cannabis

Beyond ratings and reviews, Budist is also tackling one of the industry’s most persistent challenges: the lack of education around products. Miranda points out that cannabis is often reduced to a race to the bottom, where products are judged primarily on low prices and high THC percentages.

By introducing expert-driven evaluations, Budist aims to help consumers understand why some products command a higher price, just as wine drinkers learn to distinguish between a $10 and a $100 bottle. The platform also shines a spotlight on cultivators and brands that invest in craftsmanship, such as high-quality sun-grown flower, which is often undervalued in today’s market.

“Education is key,” Miranda explained. “Some consumers want value products, and that’s fine. But others are willing to pay more for craftsmanship and quality, and they want to know why that product is worth the premium. That’s where we come in—helping consumers make sense of the differences.”

Budist vs. Ganjier: Complementary Roles

Because Budist is often compared to the Ganjier program, Miranda clarifies the distinction and how they complement one another.

  • Ganjier, founded by renowned cultivator Kevin Jodrey, is the industry’s first sommelier-style certification program. It provides deep product knowledge, professional credentials, and evaluation training similar to earning a degree.
  • Budist is a platform. It gives certified experts, including many Ganjiers, an outlet to apply their skills in the marketplace.

In addition to expert reviews, Budist also includes consumer ratings, creating a dual system modeled after platforms like Rotten Tomatoes, where both critics and everyday users contribute.

 

“Both perspectives are valid,” Miranda said. “Our professionals might include Ganjiers, longtime competition judges, journalists, or educators, but they all share a commitment to standardized, unbiased product evaluation. At the same time, consumer input provides balance and insight into what everyday users value.”

 

Together, programs like Ganjier and platforms like Budist help professionalize cannabis evaluation, giving the industry tools to recognize quality while also educating consumers about the nuances that distinguish one product from another.

California vs. New York: Different Stages, Different Stories

One of the most compelling aspects of the MJBowl will be seeing how winners differ between California and New York.

California has had a legal cannabis framework for over 20 years and is a hub of innovation for brands, product formats, retail experiences, and cultivation and extraction methods. New York’s regulated market, by contrast, is still in its early stages. While its traditional market is longstanding, the legal side has fewer brands and less product diversity, making it more of a developing market than a mature one.

It’s not just about the products. Each MJ Bowl competition reflects the culture of its state. In New York, social equity license holders make up a majority of the market, accounting for approximately 54 percent across cultivation, manufacturing, and retail. Many of these operators come from the legacy market and support one another as they transition into the legal industry. Growers supply brands, brands support retailers, and retailers provide visibility for their community peers. This longstanding network of collaboration is now thriving in the regulated space, giving New York’s cannabis scene a uniquely cooperative spirit.

California, by contrast, brings decades of product innovation and a deep bench of brands, with judges steeped in West Coast cannabis culture. New York’s judging team is being built from within its own community. “This isn’t about California going to New York and telling them what we think of their products,” Miranda said. “It’s about letting each market speak for itself, from producers to consumers and professionals alike.”

How Judges Decide What Wins

According to Miranda, winning products don’t follow a single formula; trends, innovation, and what’s bubbling up in the market all matter. Years ago, hydrocarbon extracts such as shatter and wax dominated competitions, while today’s connoisseurs favor solventless products like rosin. Edibles have evolved from simple brownies to precisely dosed chocolates, beverages, and nanotech-infused products. Judges also reward innovation across hardware and packaging, not just flower or concentrates.

Budist is working to elevate standards by implementing a 100-point evaluation rubric that scores aroma, flavor, appearance, and effect, weighted differently according to category. For example, concentrates are judged heavily on aroma and flavor, while medicinal capsules are judged primarily on whether they deliver the promised effect.

The scoring system also recognizes that consumer expectations vary widely across categories. “You can’t measure rosin against distillate and call one better than the other; they’re different products serving different purposes,” Miranda explained. That’s why products compete within subcategories, ensuring fair comparisons and allowing each style to shine on its own merits.

For the MJBowl, there are five main competition categories:

  • Flower
  • Pre-rolls
  • Vaporizers
  • Concentrates
  • Edibles

Within these, entries are divided into 11 subcategories—such as distillates, live resin, solventless extracts, chocolates, gummies, and beverages to ensure recognition across the full spectrum of cannabis products.

What Winners Receive

In addition to honoring winners on the national stage at MJBizCon, the MJBowl ups the stakes with event tickets, an awards show entry, and a travel voucher to Las Vegas. Winning brands also gain major visibility through post-event press coverage, Budist social promotion, and amplification from MJBiz.

Retail partners in each state, such as The Artist Tree, with 10 California locations, and Gotham, with four dispensaries in New York, have committed to showcasing winners on their shelves.

“This isn’t an award that disappears once the show ends,” Miranda said. “It translates directly into new opportunities for brands. So we hope everybody enters.”

 

Hear Claudio Miranda’s full interview on the Innovating Cannabis Podcast and YouTube.

Arizona Commands the Nation’s Highest Cannabis Business Valuations

By , Gordon K. Sattro
No Comments

Whether it’s a single retail license, a multi-site operation, or a vertically integrated enterprise, deals in Arizona are fetching top-tier premiums – often exceeding price points in larger, more mature markets like California.

So, what’s driving these sky-high valuations? More importantly, how can industry players take advantage? Let’s break it down.

Arizona: Where Cannabis Assets Command a Premium

Over the past 24 months, dozens of transactions have closed in Arizona by way of consolidation, ranging from single dispensary sales to multi-unit portfolio deals. The results have been record-setting: in some cases a standalone retail license has sold for over $10 million, a figure unheard of in many other states. Arizona’s cannabis assets are, in a word, premium and are routinely attracting bids that surpass those in traditionally dominant market.. Clearly, Arizona has become a market where cannabis assets command a serious premium.

Why is this desert market so hot? Below are five key factors fueling Arizona’s elevated valuations.

Five Key Factors Driving Arizona’s Sky-High Cannabis Valuations

  1. Limited License Structure: Arizona’s cannabis market operates under a tightly restrictive license cap, with only 169 dispensary licenses statewide. This built-in scarcity means any available license instantly becomes a coveted asset. With far fewer retail outlets than demand requires, sellers hold the leverage – and can command steep prices as a result.
  2. Dual Licensure (Medical + Recreational): Many Arizona licenses are dual-use, meaning one license allows both medical and adult-use sales. This doubles a dispensary’s potential customer base overnight. Dual licensure translates to higher revenue per store, as each licensed operator can serve all segments of the market. Buyers are willing to pay a premium for this versatility and expanded market share.
  3. Strategic Location and Growing Consumer Base: Arizona boasts one of the fastest-growing populations in the U.S., with major metros like Phoenix and Tucson expanding rapidly. The state also enjoys booming tourist traffic and steady streams of interstate shoppers (especially from nearby prohibition states such as Texas, Utah, and New Mexico). On top of that, Arizona offers a favorable business climate with relatively low taxes and fees, which further boosts profitability for operators. In short, demand is high and operating costs are relatively manageable which all results in a perfect recipe for rich valuations.
  4. Robust Sales and Profitability: Thanks to limited competition and dual-use sales, Arizona dispensaries tend to generate strong revenues and healthy profit margins. Each store services a large customer pool, often resulting in higher sales per dispensary than in states with more saturated markets. Buyers see that Arizona operations can yield a significant return on investment, which justifies paying top dollar for a foothold in the market.
  5. Strong Investor Demand: The buzz around Arizona has drawn in deep-pocketed buyers from across the country. Green Life has witnessed both institutional investors and high-net-worth individuals eagerly bidding for Arizona licenses and companies. This competitive buyer pool pushes valuations even higher – it’s not uncommon to see bidding wars drive a sale price well above the initial asking. When multiple buyers are vying to enter or expand in Arizona, sellers ultimately reap the reward in the form of lofty sale prices.

Navigating the Arizona Market: Buyers and Sellers

Buyers: How to Win in a Hot Market
For buyers, Arizona’s high valuations mean you must come prepared. To successfully acquire an asset in this competitive market, buyers should:

  • Be ready to move quickly. Attractive opportunities often trigger bidding wars, so speed and decisiveness are essential once a viable deal hits the market.
  • Expect to pay a premium. Understand that Arizona assets are expensive for good reason – low-ball offers won’t win deals here. Savvy buyers budget for top-tier prices and focus on the long-term upside.
  • Leverage local expertise. Partnering with experienced cannabis brokers or advisors (like Green Life Business) who know the Arizona landscape can help you identify opportunities early and navigate the complex regulatory environment with confidence.

Sellers: How to Maximize Your Sale
For sellers, Arizona’s moment in the spotlight presents a prime opportunity – but preparation is key to capturing maximum value. Green Life Business guides sellers through critical steps to capitalize on the market, including:

  • Packaging the business for maximum value. We help organize financials, compliance records, and growth stories into a compelling presentation that attracts top-tier buyers.
  • Securing pre-qualified buyers. Through an extensive network, we screen and line up buyers who have the interest and the funds, ensuring a smoother sale process.
  • Navigating regulatory hurdles. From state licensing rules to local regulations, our team helps sellers handle all compliance and license transfer requirements without derailment.
  • Closing quickly and transparently. We strive for deals that close on time, with no surprises, giving both parties confidence from offer to final handshake.

By taking these steps, sellers can tap into Arizona’s aggressive pricing environment and drive their deal to the finish line efficiently.

Bottom Line


Arizona isn’t just hot – it’s on fire. In a market where asset values elsewhere are cooling, Arizona continues to deliver record-setting valuations fueled by scarcity, strong demand, and proven profitability.

With experience selling High Times, Statehouse, and securing the largest all-cash cannabis transaction since 2022, Green Life Business has the expertise and track record to position your Arizona business for the strongest possible sale outcome. Whether you’re considering an exit, recapitalization, or expansion, our team brings the market knowledge and deal execution needed to maximize value.

Let’s talk. The next great Arizona transaction could be yours.

Greenlife Business Group Inc.

STIIIZY Expands by Opening 44th Retail Store

By Cannabis Industry Journal Staff, Rick Biros
No Comments

The STIIIZY Hawthorne grand opening marks the company’s ninth retail store launch in the past year — proving how the brand recognizes the growing demand and is answering the call to bring its quality products to consumers by scaling its operations in licensed states with a successful expansion strategy.

  The U.S. cannabis brand STIIIZY is expanding its footprint with the opening of its newest retail location in Hawthorne, CA. As the brand’s 44th dispensary, the new storefront is located at 12831 Crenshaw Blvd, Hawthorne, CA.
  Perfectly located on Crenshaw Blvd at El Segundo Blvd, STIIIZY Hawthorne is a convenient stop for South Bay locals and tourists alike. Designed for the modern cannabis consumer, STIIIZY Hawthorne provides a sleek, welcoming environment and a knowledgeable team ready to help its customers find the perfect product for their needs. For seasoned aficionados or those who are new to the cannabis scene, the STIIIZY Hawthorne dispensary offers an extensive selection of premium products, including world-class flower, innovative concentrates, delicious edibles, and state-of-the-art accessories.
  The STIIIZY Hawthorne grand opening marks the company’s ninth retail store launch in the past year — proving how the brand recognizes the growing demand and is answering the call to bring its quality products to consumers by scaling its operations in licensed states with a successful expansion strategy.
  “STIIIZY Hawthorne is more than just a dispensary, it’s a hub for cannabis culture in the South Bay. As we continue to expand and establish our brand’s presence across the map, it’s especially meaningful to continue this growth within our home state of California—where it all started,” said Tak Sato, President at STIIIZY. “With our roots here, every California store we open reinforces our deep connection to the local communities that have supported us from the beginning. Now with 44 operating stores, we are dedicated to bringing STIIIZY to more markets statewide and beyond.”

Sustainability in Cannabis Packaging: Balancing Preservation and Environmental Impact

By Jack Grover
2 Comments

Even a cursory review of cannabis reveals that the market has been notoriously wasteful, polluting the environment with chemical fertilizers, misused pesticides, contaminated plants, and—perhaps most problematically—thoughtlessly excessive packaging.

The industry is in dire need of sustainable practices, and the easiest way to start an impactful new trend is from the outside in: a.k.a., adjusting how you’re parceling your products.

Honing in on sustainable packaging isn’t just a good move for the environment. It’s also more cost-effective, less labor-intensive and allows you to provide consumers with the best possible version of your flower—no matter how far through the supply chain it’s had to travel before hitting retail shelves.

Cannabis has progressed: It’s time for its packaging to do the same

By the time legalization began sweeping the nation, the industry already had several decades of experience operating underground. With that discretion came a lot of built-in habits around not attracting attention, and for packaging, the focus was solely on not looking like a cannabis product.

An overabundance of plastic isn’t cutting it anymore—not only when it comes to environmental friendliness, but for the integrity of the product itself.

Today, increased legalization grants operators the freedom to expand without the fear of being seen, and as a result, there’s no longer any excuse for wasteful packaging to be the industry’s norm. Glass jars, Ziplocks and an overabundance of plastic isn’t cutting it anymore—not only when it comes to environmental friendliness, but for the integrity of the product itself.

“I’ve been designing packaging in the cannabis industry since 2013, and a lot of trends have come and gone. We used to put flower in plastic Rx jars and paper envelopes. In general, there was a lot of waste: excess boxes and jars that all get thrown away,” says Legacy’s Chief Cannabis Officer Ryan Hedrick. “And when consumers pull the products out of those containers, your marketing doesn’t remain intact. The box gets thrown away, and now they’re just carrying around a labelless jar. Not only is it bad for the environment, but it isn’t helping you promote your brand at all.”

How sustainable storage optimizes curing and shelf life of flower

As for the curing process, Hedrick used to use airtight buckets, which both took up a lot of room and wasn’t at all effective for maintaining cannabis’s ideal humidity levels. He’s since switched to passive atmospheric packaging, which utilizes increasingly popular technology to keep humidity—and sustainability—in mind. “The buckets weren’t letting any moisture out. On top of that, you can imagine how much room 165 five-gallon buckets takes up in a grow space,” Hedrick says.

The same goes for long-term storage. With humidity-controlled bags, operators can rest assured that their product will maintain its efficacy, because as soon as that pack is sealed, the humidity level is guaranteed to stay the same.

Cannabis brand Lava Leaf Organics relies on passive atmospheric packaging for efficient storage—mainly because of the reduction in carbon footprint and increase in terpene preservation.

“When we think about the energy involved in packaging and shipping large amounts of heavy glass jars compared to TerpLoc bags, it was an easy decision for us,” said Lava Leaf Organics CEO Tony Martinez.

“The bags are recyclable, and compared to glass jars with child-resistant lids, they’re much better at preserving terpenes. Using sustainable packaging allows us to put our best foot forward and to better control our customer’s brand experience.”

Tips for making sustainable storage work for you

Sustainable storage is an environmentally-responsible move for the cannabis industry to make, but when weighing the pros and cons of a big switch like this, operators should also keep in mind how positively it will impact their end product, consumer’s experience, and, subsequently, their industry-wide reputation.

Some product packaging examples in the market today

Placing your products in eco-friendly bags is just the start. There are definitely more tips and tricks operators can take advantage of to prolong the use of sustainable materials and ensure they’re leaving as small a footprint as possible. For example, Hedrick’s team reuses their passive atmospheric packaging for maximum efficiency—especially when it comes to bulk storage or curing.

“We mark all of our storage bags with the original strain, so we can reuse that bag for the same strain as long as it passes testing along the way. When I do so, I take a mixture of SaniDate and water to make sure everything is sanitized and clean,” Hedrick said. “That allows me to reuse them for about 3-4 months’ worth of curing and storage. You can reuse a bucket in that same way, but when it’s time to replace it, you’re still spending another $15-$17.”

Sustainable, humidity-controlled packaging is also ideal for testing consistency. If you send in five buckets of the same strain to be tested, you run the risk of them all sitting at wildly different humidity levels, which means some might pass, and others might be rendered trash.

All of the environmental benefits aside, using sustainable packaging just makes cents—literally. “Essentially, I’m saving a minimum of half a million in packaging every year. That’s my entire staff’s salary for two months. That’s incredible, impactful, significant savings that can make a huge difference for a business trying to expand.”

Cannabis in Texas: A Look Ahead to Legalization and Beyond

By Abraham Finberg, Rachel Wright, Simon Menkes
1 Comment

A Uniquely Texas Approach to Cannabis

The last few decades have seen the United States move forward state-by-state with the legalization of cannabis. Every state is charting its own unique path, and nowhere is this truer than with the state of Texas.

The Lone Star State has made its way from being staunchly anti-cannabis to expressing its own blend of temperance and careful action, combined with a medical cannabis program that’s expanding.

Any predictions regarding the future of cannabis in Texas must take into consideration both the state’s past and its values. In the end, it’s clear that Texas will embrace cannabis in its own individual way and at its own pace, but with a timeframe that appears to be arriving sooner rather than later.

The Debate Continues

108 years after Texas first banned cannabis and the debate continues. Even though Texas has a medical cannabis program, cannabis is still illegal in the state, with possession of less than two ounces a misdemeanor. Possession of more than four ounces is a felony punishable by a $10,000 fine and from 2-99 years in jail.

Texas’s 2015 Compassionate Use Act created the state’s medicinal cannabis program, which now makes treatment available only in the form of low-THC oil of a maximum strength of 1%, and only to a small list of serious conditions: epilepsy, terminal cancer, autism, multiple sclerosis, amyotrophic lateral sclerosis (ALS), seizure disorders, incurable neurological disorders such as Alzheimer’s, Parkinson’s, Huntington’s Disease and PTSD.

Support for a Stronger Medicinal Cannabis Program Comes from Prominent Politicians

Texas Department of Agriculture Commissioner Sid Miller, a leader in Texas politics and one of the architects of Texas’s burgeoning hemp industry, has encouraged Texas legislators to create a more complete medical cannabis program.

Texas Department of Agriculture Commissioner Sid Miller

“I am for medical use,” Miller said in an August 2023 interview. “We have so much good science now. And we know what diseases it can treat, yet our legislature picks winners [and] losers. If you’ve got this disease, you can get treated, but if you’ve got this disease and cannabis will help you, you can’t get treated. We need to let the doctor-patient relationship make those medical decisions and not some bureaucrat or some politician … I’m not a supporter of recreational marijuana, but if someone has a condition that this chemical will help, they should be able to use it.”

Texas Representative Joe Moody from El Paso has worked for many years to promote adult-use cannabis. He recently co-authored two pro-cannabis bills, HB 1805, which would have expanded covered medical conditions and defined a per-doze THC limit instead of a percentage limit on cannabis products, and HB 218, which would have decriminalized cannabis.

Although both bills passed the House of Representatives, they were stopped in the Senate. The next session of the state legislature, which happens every two years, won’t begin until January 2025, so that is the earliest any change in cannabis statutes could take place.

The Future of Medicinal Cannabis

There are currently only three dispensaries in Texas. They appear to be servicing the state’s 268,000 square miles through a series of weekly drop-offs to satellite “partner locations,” which are open an average of only two days per week. This is not exactly a corner-CVS type of arrangement, and the need for new dispensaries for the state’s 61,000 registered patients is high.

The Texas Department of Public Safety took applications for new medical dispensary licenses between January and April 2023. Tony Gallo, managing partner of Sapphire Risk Advisory Group, which helped twelve licensees prepare their applications during this round, anticipates around ten new dispensaries being approved.

All licensees must be vertically integrated – product must go from seed-to-sale under one license – and each applicant paid $7,356 to apply. If approved, the applicants will owe another $488,520.00 for a two-year period.

Many knowledgeable Texans, including Agriculture Commissioner Sid Miller, predict a fully-functioning medicinal cannabis market is just a few years away. “If you can get it to the floor, probably 70% or 80% of the legislative body will vote in favor of it because we have such good science on it. [Originally] we thought, ‘Well, that’ll lead to recreational use or more drug use,’ but it’s not. It’s a plant derivative. Medical marijuana is not nearly as addictive as some of the prescription drugs we use now.”

The Push is On for Adult-Use

Representative Joe Moody believes that adult-use is not too far away in Texas’s future either, and that the way to speed its arrival is through education. He recently sponsored HB 3652, the Texas Regulation & Taxation of Cannabis Act, in order to start a dialogue on what a retail cannabis market will look like in Texas.

Texas Representative Joe Moody

On April 26, 2023, Moody and his bill received a public hearing in the House Committee for Licensing and Administrative Procedures in which many points about setting up a retail market in Texas were discussed. A 10% cannabis tax was proposed by Moody, to be split evenly between the state and local government. Licenses would be required for those growing, selling, transporting or testing cannabis, although individuals would be allowed to grow or possess it in small amounts for personal use. Legal sale and consumption would be limited to adults 21 years of age and older, like alcohol. And of course, cannabis possession would be decriminalized.

How Strong is the Market Potential for Cannabis?

One indication of how strong even a fully-open medical cannabis market might be in Texas came during Moody’s hearing from the testimony of Estella Castro. Castro owns two medical dispensaries in Oklahoma just across the state line from Texas and suspects most her buyers are from Texas. “They have a Texas plate and they come in and buy $500 to $600 worth of product,” she said. Her two shops generated $158,000 in taxes to Oklahoma, most of which she believes should have gone to Texas.

New Mexico recently legalized adult-use cannabis, and the small towns along the Texas-New Mexico border are seeing a lot of traffic from Texas. In the first week of adult-use sales, the New Mexico did adult-use sales totaling $6 million. Of those sales, $1.5 million came from dispensaries in 5 small border towns.

Florida and California Suggest the Scope of a Mature Cannabis Market in Texas

The potential for a fully developed medical cannabis market can be gleaned by studying the next smaller state, Florida, which has an open, mature, medical cannabis market. Florida, with 20 million people, is about two-thirds the size of Texas, which has 30 million inhabitants. Right now, Florida boasts 700,000 cannabis patients whereas Texas only has 61,000. Simple math suggests a fully open, mature, medical cannabis market in Texas could see over a million patients gain relief.

California is the nation’s most populous state with 39 million inhabitants, and its cannabis revenue gives some perspective as to the size of a Texas adult-use market. 2024 estimates of California’s cannabis revenue suggest the Golden State will see $7.2 billion legal cannabis sales while the illegal market will generate another $6.4 billion for a total of $13.6 billion. With a reduction for Texas’s smaller size, these numbers suggest a fully-mature Texas adult-use cannabis market could generate close to $10 billion in annual revenue.

Large adult-use states like California and New York are notorious for having an illicit market that threatens to derail their legal, tax-paying cannabis license holders. Texas’s strong business-friendly focus should help deter such an illicit marketplace from gaining too significant a foothold.

The Back-Door Cannabis Industry

Meanwhile, an extensive “back door” cannabis industry is in full swing in Texas. CBD shops now sell delta-9 (fully psychoactive) THC/CBD gummies and tinctures made from the hemp plant, which is the low THC-version of the cannabis plant. These THC/CBD products adhere to the 0.3% definition of hemp as required by the federal 2018 Farm Bill and are legal and available for over-the-counter or online purchase in Texas’s CBD stores.

Gummies, tinctures and other products made form them hemp plant

Current estimates are that there are over 5,000 hemp, CBD and cannabinoid retailers, manufacturers and distributors in Texas that employ more than 50,000 workers and generate more than $8 billion in annual revenue. With these numbers, the 1,100+ licensed Texas hemp growers are sitting well where they are and are poised to take advantage of a legal adult-use market if and when Texas decides it is ready to go down that path.

Next Steps for Texas’s Cannabis Market

People familiar with Texas’s cannabis market believe that adult-use is a ways down the road for the Lone Star State, and that the near-term focus needs to be on decriminalization and achieving an unincumbered medical cannabis system. Tony Gallo of Sapphire Risk Advisory Group advises the Texas cannabis community to concentrate on “increasing what conditions are allowed for medicinal use” and “increasing what areas of the state it’s allowed to be sold.”

There is a groundswell of public support for decriminalizing cannabis as well as for allowing adult-use. A December 2022 poll showed 55% of Texans support legalizing at least small amounts of cannabis for recreational purposes, and another 28% said it should be legal for medicinal purposes.

A February 2023 poll by the University of Houston found that 82% of Texans support the Legislature passing a bill that would allow people to use marijuana for a wide range of medical purposes with a prescription. The belief that cannabis is a “gateway drug” that would make people more likely to use other illegal drugs is losing traction as well – 70% said it would make people less likely to do so or would have no impact.

Final Thoughts

The demand for cannabis in the Lone Star State is strong. With the likelihood of a fully-functioning medical cannabis market coming soon, and the possibility of decriminalization not too far behind, it’s clear that the future of cannabis is bright in Texas.

While the legalities around adult-use will take longer to work out, and the place of hallucinogenic hemp in the mix needs to be examined and clarified, one fact is certain. The path forward that Texas cannabis takes will certainly be a unique one, as unique and as individual as the Texan people themselves.